Yunnan Baiyao: JZ-14 Capsules Receive Approval for Drug Clinical Trials.

Yunnan Baiyao announced on the evening of June 17 that its controlling subsidiary, Yunbaiyao Zhengwu Technology Co., Ltd., recently received the "Drug Clinical Trial Approval Letter" issued by the National Medical Products Administration. Upon review, the clinical trial application for JZ-14 capsules by Zhengwu Technology meets the relevant requirements for drug registration, and it is approved to conduct clinical trials for ulcerative colitis with this product.